Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
-
2020 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Corrigendum to “Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines”In: Experimental Cell Research Jg. 426 (2023) Nr. 1,ISSN: 0014-4827; 1090-2422Online Volltext: dx.doi.org/
-
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancerIn: Translational Oncology Jg. 15 (2022) Nr. 1,ISSN: 1936-5233; 1944-7124Online Volltext: dx.doi.org/ (Open Access)
-
Detection and Validation of Circular DNA Fragments Using Nanopore SequencingIn: Frontiers in Genetics Jg. 13 (2022)ISSN: 1664-8021Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastomaIn: Cell Death Discovery Jg. 8 (2022) Nr. 1,ISSN: 2058-7716Online Volltext: dx.doi.org/ (Open Access)
-
Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancerIn: Cell Death and Disease Jg. 13 (2022) Nr. 6,ISSN: 2041-4889Online Volltext: dx.doi.org/ (Open Access)
-
The clinical utility of cfRNA for disease detection and surveillance : A proof of concept study in non-small cell lung cancerIn: Thoracic Cancer (2022) in pressISSN: 1759-7714; 1759-7706Online Volltext: dx.doi.org/ (Open Access)
-
Zebrafish as an Orthotopic Tumor Model for Retinoblastoma Mimicking Routes of Human MetastasisIn: Cancers Jg. 14 (2022) Nr. 23,ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
Anticancer Effects of Viscum album Fraxini Extract on Medulloblastoma Cells in vitroIn: Complementary Medicine Research Jg. 28 (2021) Nr. 1, S. 15 - 22ISSN: 2504-2106; 2504-2092Online Volltext: dx.doi.org/
-
Antitumoral Effects of Curcumin (Curcuma longa L.) and Thymoquinone (Nigella sativa L.) on Neuroblastoma Cell LinesIn: Complementary Medicine Research Jg. 28 (2021) Nr. 2, S. 164 - 168ISSN: 2504-2106; 2504-2092Online Volltext: dx.doi.org/
-
Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastomaIn: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 5,ISSN: 2051-1426Online Volltext: dx.doi.org/ (Open Access)
-
HER2 mediates clinical resistance to the KRASG¹²C inhibitor sotorasib, which is overcome by co-targeting SHP2In: European Journal of Cancer (EJC) Jg. 159 (2021) S. 16 - 23ISSN: 1879-0852; 0959-8049; 1879-2995Online Volltext: dx.doi.org/
-
NTRK1/TrkA activation overrides the G₂ /M-checkpoint upon irradiationIn: Cancers Jg. 13 (2021) Nr. 23,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Ntrk1/trka signaling in neuroblastoma cells induces nuclear reorganization and intra‐nuclear aggregation of lamin a/cIn: Cancers Jg. 13 (2021) Nr. 21,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Präklinische Untersuchungen von Wechselwirkungen zwischen Mistel und Radio- oder Chemotherapie auf pädiatrische TumorzellenIn: Complementary Medicine Research (2021) in pressISSN: 2504-2106; 2504-2092Online Volltext: dx.doi.org/
-
Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasisIn: Cell Reports Jg. 37 (2021) Nr. 8,ISSN: 2211-1247Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastomaIn: Cell Death & Disease Jg. 12 (2021) Nr. 10,ISSN: 2041-4889Online Volltext: dx.doi.org/ (Open Access)
-
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasisIn: Oncogenesis Jg. 9 (2020) Nr. 11, S. 102ISSN: 2157-9024Online Volltext: dx.doi.org/ (Open Access)
-
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma modelIn: Lung Cancer Jg. 144 (2020) S. 20 - 29ISSN: 1872-8332; 0169-5002Online Volltext: dx.doi.org/
-
Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK PathwayIn: Cancer Research Jg. 80 (2020) Nr. 21, S. 4655 - 4667ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ (Open Access)
-
Maxillofacial injuries in severely injured patients after road traffic accidents—a retrospective evaluation of the TraumaRegister DGU® 1993–2014In: Clinical Oral Investigations Jg. 24 (2020) Nr. 1, S. 503 - 513ISSN: 1436-3771; 1432-6981Online Volltext: dx.doi.org/ (Open Access)
-
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaIn: Scientific Reports Jg. 10 (2020) Nr. 1, S. 7157ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancerIn: Cancers Jg. 12 (2020) Nr. 2, S. 353ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Streamlining quantitative analysis of long RNA sequencing readsIn: International Journal of Molecular Sciences (IJMS) Jg. 21 (2020) Nr. 19, S. 7259ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4⁺ CAR T Cell EfficacyIn: Frontiers in Immunology Jg. 11 (2020) S. 531ISSN: 1664-3224Online Volltext: dx.doi.org/ (Open Access)
-
Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell linesIn: Experimental Cell Research Jg. 375 (2019) Nr. 2, S. 92 - 99ISSN: 0014-4827; 1090-2422Online Volltext: dx.doi.org/ (Open Access)
-
Custom wave-shaped CAD/CAM orbital wall implants for the management of post-enucleation socket syndromeIn: Journal of Cranio-Maxillofacial Surgery Jg. 47 (2019) Nr. 9, S. 1398 - 1405ISSN: 1878-4119; 1010-5182; 0301-0503Online Volltext: dx.doi.org/
-
Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activityIn: MedChemComm Jg. 10 (2019) Nr. 7, S. 1109 - 1115ISSN: 2040-2511; 2040-2503Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Factors influencing the long-term prognosis of root tip resected teethIn: GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW Jg. 8 (2019) S. 13ISSN: 2193-8091Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Large expert-curated database for benchmarking document similarity detection in biomedical literature searchIn: Database: The Journal of Biological Databases and Curation Jg. 2019 (2019) S. 1 - 67ISSN: 1758-0463Online Volltext: dx.doi.org/ (Open Access)
-
Preclinical Evaluation of Antitumoral and Cytotoxic Properties of Viscum album Fraxini Extract on Pediatric Tumor CellsIn: Planta Medica Jg. 85 (2019) Nr. 14-15, S. 1150 - 1159ISSN: 1439-0221; 0032-0943Online Volltext: dx.doi.org/
-
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastomaIn: Cancer Letters Jg. 455 (2019) S. 24 - 33ISSN: 0304-3835; 1872-7980Online Volltext: dx.doi.org/
-
Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell linesIn: European Journal of Gynaecological Oncology (EJGO) Jg. 40 (2019) Nr. 1, S. 106 - 112ISSN: 0392-2936; 2709-0086Online Volltext: dx.doi.org/
-
Unbreakable? – Frakturen patientenspezifischer Implantate nach alloplastischer UnterkieferrekonstruktionIn: Der MKG-Chirurg Jg. 12 (2019) Nr. 4, S. 263 - 267ISSN: 1865-9659; 1865-9667Online Volltext: dx.doi.org/
-
A mechanistic classification of clinical phenotypes in neuroblastomaIn: Science Jg. 362 (2018) Nr. 6419, S. 1165 - 1170ISSN: 1095-9203; 0036-8075Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Cancer evolution, mutations, and clonal selection in relapse neuroblastomaIn: Cell and Tissue Research Jg. 372 (2018) Nr. 2, S. 263 - 268ISSN: 0302-766X; 1432-0878Online Volltext: dx.doi.org/
-
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsIn: JCI Insight Jg. 3 (2018) Nr. 23,ISSN: 2379-3708Online Volltext: dx.doi.org/ (Open Access)
-
Evolution of melanoma cross-resistance to CD8⁺ T cells and MAPK inhibition in the course of BRAFi treatmentIn: OncoImmunology Jg. 7 (2018) Nr. 8,ISSN: 2162-402X; 2162-4011Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Risk factors for post-operative complications after procedures for autologous bone augmentation from different donor sitesIn: Journal of Cranio-Maxillofacial Surgery Jg. 46 (2018) Nr. 2, S. 312 - 322ISSN: 1878-4119; 1010-5182; 0301-0503Online Volltext: dx.doi.org/
-
Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapyIn: Complementary Therapies in Medicine Jg. 40 (2018)ISSN: 1873-6963; 0965-2299Online Volltext: dx.doi.org/
-
The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human diseaseIn: OncoTarget Jg. 9 (2018) Nr. 9, S. 8334 - 8349ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
TrkB-Target Galectin-1 Impairs Immune Activation and Radiation Responses in Neuroblastoma : Implications for Tumour TherapyIn: International Journal of Molecular Sciences (IJMS) Jg. 19 (2018) Nr. 3, S. 718ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Accelerating drug development for neuroblastoma - New Drug Development Strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma projectIn: Expert Opinion on Drug Discovery Jg. 12 (2017) Nr. 8, S. 801 - 811ISSN: 1746-045X; 1746-0441Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionIn: OncoImmunology Jg. 6 (2017) Nr. 6,ISSN: 2162-402X; 2162-4011Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Application of the PAMONO-sensor for quantification of microvesicles and determination of nano-particle size distributionIn: Sensors Jg. 17 (2017) Nr. 2, S. 244ISSN: 1424-8220Online Volltext: dx.doi.org/ (Open Access)
-
Overcoming drug resistance by cell-penetrating peptide-mediated delivery of a doxorubicin dimer with high DNA-binding affinityIn: European Journal of Medicinal Chemistry Jg. 130 (2017) S. 336 - 345ISSN: 1768-3254; 0223-5234Online Volltext: dx.doi.org/
-
Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell linesIn: Clinical & Experimental Ophthalmology Jg. 45 (2017) Nr. 3, S. 288 - 296ISSN: 1442-9071; 1442-6404Online Volltext: dx.doi.org/
-
RITA displays anti-tumor activity in medulloblastomas independent of TP53 statusIn: OncoTarget Jg. 8 (2017) Nr. 17, S. 27882 - 27891ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Targeting tachykinin receptors in neuroblastomaIn: OncoTarget Jg. 8 (2017) Nr. 1, S. 430 - 443ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma modelsIn: OncoTarget Jg. 8 (2017) Nr. 4, S. 6730 - 6741ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsIn: OncoTarget Jg. 7 (2016) Nr. 46, S. 74415 - 74426ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2In: PLoS ONE Jg. 11 (2016) Nr. 10, S. e0163648ISSN: 1932-6203Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Immune response modulation by Galectin-1 in a transgenic model of neuroblastomaIn: OncoImmunology Jg. 5 (2016) Nr. 5,ISSN: 2162-402X; 2162-4011Online Volltext: dx.doi.org/ (Open Access)
-
MYCN-targeting vaccines and immunotherapeuticsIn: Human Vaccines & Immunotherapeutics Jg. 12 (2016) Nr. 9, S. 2257 - 2258ISSN: 2164-554X; 2164-5515; 1554-8619; 1554-8600Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Targeting MYCN-driven transcription by BET-bromodomain inhibitionIn: Clinical Cancer Research Jg. 22 (2016) Nr. 10, S. 2470 - 2781ISSN: 1557-3265; 1078-0432Online Volltext: dx.doi.org/ (Open Access)
-
The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapseIn: OncoTarget Jg. 7 (2016) Nr. 6, S. 6620 - 6625ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Towards diagnostic application of non-coding RNAs in neuroblastomaIn: Expert Review of Molecular Diagnostics Jg. 16 (2016) Nr. 12, S. 1307 - 1313ISSN: 1473-7159; 1473-7159Online Volltext: dx.doi.org/
-
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studiesIn: Oncogene Jg. 34 (2015) Nr. 26, S. 3357 - 3368ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/ (Open Access)
-
Absence of telomerase reverse transcriptase promoter mutations in neuroblastomaIn: Biomedical Reports Jg. 3 (2015) Nr. 4, S. 443 - 446ISSN: 2162-4178; 2049-9442Online Volltext: dx.doi.org/
-
Dandelion (Taraxacum officinale) extracts supply antitumour effects of mistletoe in pediatric cancer cellsIn: Phytomedicine Jg. 22 (2015) Nr. Suppl.1, S. S25 - S26ISSN: 0944-7113Online Volltext: dx.doi.org/
-
MiR-34a deficiency accelerates medulloblastoma formation in vivoIn: International Journal of Cancer Jg. 136 (2015) Nr. 10, S. 2293 - 2303ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Mutational dynamics between primary and relapse neuroblastomasIn: Nature Genetics Jg. 47 (2015) Nr. 8, S. 872 - 877ISSN: 1061-4036; 1546-1718Online Volltext: dx.doi.org/
-
Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumorsIn: OncoTarget Jg. 6 (2015) Nr. 17, S. 15425 - 15435ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in miceIn: Cancer Immunology, Immunotherapy Jg. 64 (2015) Nr. 10, S. 1215 - 1227ISSN: 0340-7004; 1432-0851Online Volltext: dx.doi.org/
-
Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastomaIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. 4731ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Telomerase activation by genomic rearrangements in high-risk neuroblastomaIn: Nature Jg. 526 (2015) Nr. 7575, S. 700 - 704ISSN: 0028-0836; 1476-4687Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Telomerase activation by genomic rearrangements in high-risk neuroblastomaIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. LB - 210ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
The current state of facial prosthetics : A multicenter analysisIn: Journal of Oral and Maxillofacial Surgery Jg. 43 (2015) Nr. 7, S. 1038 - 1041ISSN: 1531-5053; 0278-2391Online Volltext: dx.doi.org/
-
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating SurvivinIn: International Journal of Cancer Jg. 136 (2015) Nr. 6, S. 1308 - 1320ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Neuroblastoma in dialog with its stroma : NTRK1 is a regulator of cellular cross-talk with Schwann cellsIn: OncoTarget Jg. 5 (2014) Nr. 22, S. 11180 - 11192ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsamplingIn: PLoS ONE Jg. 9 (2014) Nr. 10, S. e108818ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
BET bromodomain protein inhibition is a therapeutic option for medulloblastomaIn: OncoTarget Jg. 4 (2013) Nr. 11, S. 2080 - 2095ISSN: 1949-2553Online Volltext: dx.doi.org/
-
Design of a Modular Protein-Based MRI Contrast Agent for Targeted ApplicationIn: PLoS ONE Jg. 8 (2013) Nr. 6, S. e65346ISSN: 1932-6203Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Discovery of a new bioactive molecule for neuroblastomaIn: Chemical Biology and Drug Design Jg. 82 (2013) Nr. 2, S. 233 - 241ISSN: 1747-0277; 1747-0285; 1397-002X; 1399-3011Online Volltext: dx.doi.org/
-
Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cellsIn: International Journal of Cancer Jg. 133 (2013) Nr. 4, S. 908 - 919ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Focal DNA copy number changes in neuroblastoma target MYCN regulated genesIn: PLoS ONE Jg. 8 (2013) Nr. 1, S. e52321ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Identifying transcriptional miRNA biomarkers by integrating high-throughput sequencing and real-time PCR dataIn: Methods: A Companion to Methods in Enzymology Jg. 59 (2013) Nr. 1, S. 154 - 163ISSN: 1095-9130; 1046-2023Online Volltext: dx.doi.org/
-
LIN28B drives neuroblastoma oncogenesis through let7-MYCN signalingIn: Cancer Research Jg. 73 (2013) Nr. 8 Suppl. 1, S. 4596ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cellsIn: Oncogene Jg. 32 (2013) Nr. 8, S. 1059 - 1065ISSN: 1476-5594; 0950-9232Online Volltext: dx.doi.org/
-
MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1AIn: International Journal of Cancer Jg. 133 (2013) Nr. 5, S. 1064 - 1073ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAsIn: Oncogene Jg. 32 (2013) Nr. 24, S. 2927 - 2936ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interactionIn: Scientific Reports Jg. 3 (2013) S. 1351ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastomaIn: International Journal of Cancer Jg. 132 (2013) Nr. 3, S. E106 - E115ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Targeted Therapy for Neuroblastoma : ALK InhibitorsIn: Klinische Pädiatrie Jg. 225 (2013) Nr. 6, S. 303 - 308ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Targeting the disialoganglioside GD2 in neuroblastoma using a phage display derived oligopeptideIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 40 (2013) Nr. Suppl 2, S. S295ISSN: 1619-7070; 1619-7089; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/
-
The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemiaIn: BMC Cancer Jg. 13 (2013) S. 452ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastomaIn: Acta Neuropathologica Communications Jg. 1 (2013) Nr. 1, S. 19ISSN: 2051-5960Online Volltext: dx.doi.org/ (Open Access)
-
Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcomeIn: BMC Bioinformatics Jg. 13 (2012) Nr. Suppl 4, S. 13ISSN: 1471-2105Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaIn: International Journal of Cancer Jg. 130 (2012) Nr. 11, S. 2591 - 2598ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcomeIn: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 8, S. 1409 - 1417ISSN: 1532-1827; 0007-0920Online Volltext: dx.doi.org/ (Open Access)
-
Genen auf der Spur : wie genomweite Analysen am Modell Neuroblastom zukünftige Therapiemöglichkeiten aufzeigenIn: Unikate: Berichte aus Forschung und Lehre (2012) Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 22 - 31ISBN: 978-3-934359-42-0 ISSN: 0944-6060; 1869-3881Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomasIn: International Journal of Cancer Jg. 130 (2012) Nr. 11, S. 2599 - 2606ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
LIN28B drives neuroblastoma oncogenesis through let7-MYCN signalingIn: Klinische Pädiatrie Jg. 224 (2012) S. 222ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppressionIn: Nature Genetics Jg. 44 (2012) Nr. 11, S. 1199 - 1206ISSN: 1061-4036; 1546-1718Online Volltext: dx.doi.org/
-
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiationIn: Leukemia Jg. 26 (2012) Nr. 9, S. 2039 - 2051ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/
-
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomasIn: Neuro-Oncology Jg. 14 (2012) Nr. 7, S. 859 - 869ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ (Open Access)
-
RITA-p53 activation in medulloblastoma as a new approach for treatment?In: Klinische Pädiatrie Jg. 224 (2012) S. 221ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-α-independent apoptosisIn: Cancer Research Jg. 72 (2012) Nr. 10, S. 2645 - 2656ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ (Open Access)
-
Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formationIn: Nature Cell Biology Jg. 14 (2012) Nr. 9, S. 958 - 965ISSN: 1465-7392; 1476-4679Online Volltext: dx.doi.org/
-
Targeted expression of mutated ALK induces neuroblastoma in transgenic miceIn: Science Translational Medicine Jg. 4 (2012) Nr. 141, S. 141ra91ISSN: 1946-6234; 1946-6242Online Volltext: dx.doi.org/
-
The JARID 1C histone demethylase is upregulated in aggressive neuroblastomas independent of MYCN amplificationIn: Klinische Pädiatrie Jg. 224 (2012) S. 221 - 222ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastomaIn: Cell Cycle Jg. 11 (2012) Nr. 3, S. 569 - 581ISSN: 1554-8627; 1538-4101Online Volltext: dx.doi.org/
-
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastomaIn: Oncogene Jg. 30 (2011) Nr. 25, S. 2823 - 2835ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
Detection of neuroblastoma cells during clinical follow up : advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCRIn: Klinische Pädiatrie Jg. 223 (2011) Nr. 6, S. 326 - 331ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary NeuroblastomaIn: Clinical Cancer Research Jg. 17 (2011) Nr. 15, S. 5082 - 5092ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Molecular Targets in Embryonal TumorsIn: Klinische Pädiatrie Jg. 223 (2011) Nr. 1, S. 48ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Pharmacological activation of the p53 pathway by nutlin-3 inhibits medulloblastoma cell proliferation in vitro and in vivoIn: European Journal of Pediatrics Jg. 170 (2011) Nr. 2, S. 267 - 268ISSN: 1432-1076; 0340-6199Online Volltext: dx.doi.org/
-
Polo-like kinase 1 is a therapeutic target in high-risk neuroblastomaIn: Clinical Cancer Research Jg. 17 (2011) Nr. 4, S. 731 - 741ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinomaIn: International Journal of Cancer Jg. 129 (2011) Nr. 10, S. 2390 - 2399ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitroIn: Klinische Pädiatrie Jg. 223 (2011) Nr. 3, S. 198ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Viscum album inhibits cell growth, migration and invasion of pediatric tumor cell lines - But effects are limited at concentrations found in serumIn: Phytomedicine: International Journal of Phytotherapy and Phytopharmacology Jg. 18 (2011) Nr. Suppl. 8, S. 8 - S9ISSN: 0944-7113; 1618-095XOnline Volltext: dx.doi.org/
-
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samplesIn: Clinical Cancer Research Jg. 17 (2011) Nr. 24, S. 7684 - 7692ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
384 Dicer1 is a synthetic lethal partner of tumour suppressor p53In: European Journal of Cancer / EJC Supplements Jg. 8 (2010) Nr. 5, S. 98ISSN: 1878-1217; 1359-6349Online Volltext: dx.doi.org/
-
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signatureIn: Clinical Cancer Research Jg. 16 (2010) Nr. 5, S. 1532 - 1541ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Accurate prediction of neuroblastoma outcome based on miRNA expression profilesIn: International Journal of Cancer Jg. 127 (2010) Nr. 10, S. 2374 - 2385ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumoursIn: Oncogene Jg. 29 (2010) Nr. 24, S. 3583 - 3592ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastomaIn: Clinical Cancer Research Jg. 16 (2010) Nr. 11, S. 2971 - 2978ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastomaIn: Nucleic Acids Research Jg. 38 (2010) Nr. 17, S. 5919 - 5928ISSN: 1362-4962; 0301-5610; 0305-1048Online Volltext: dx.doi.org/
-
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusionIn: Journal of Immunotherapy Jg. 33 (2010) Nr. 2, S. 200 - 210ISSN: 1524-9557; 1053-8550; 1537-4513Online Volltext: dx.doi.org/
-
KDM 1A/LSD1 has a functional role in migration of medulloblastoma cells and their neuronal precursorsIn: Klinische Pädiatrie Jg. 222 (2010) Nr. 3, S. 221ISSN: 0300-8630; 1439-3824
-
LSD1 is a novel therapeutic target in neuroblastoma (NB) and medulloblastoma (MB)In: European Journal of Pediatrics Jg. 169 (2010) Nr. 3, S. 381ISSN: 1432-1076; 0340-6199Online Volltext: dx.doi.org/
-
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumorsIn: Oncogene Jg. 29 (2010) Nr. 9, S. 1394 - 1404ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationIn: Clinical Cancer Research Jg. 16 (2010) Nr. 17, S. 4353 - 4362ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Production of chick embryo extract for the cultivation of murine neural crest stem cellsIn: Journal of Visualized Experiments Jg. 2010 (2010) Nr. 45,ISSN: 1940-087XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell linesIn: Klinische Pädiatrie Jg. 222 (2010) Nr. 3, S. 219ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in NeuroblastomaIn: Molecular Cell Jg. 40 (2010) Nr. 5, S. 762 - 773ISSN: 1097-2765; 1097-4164Online Volltext: dx.doi.org/
-
ALK Mutation Analysis in Patients of the German Neuroblastoma StudyIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 195ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Characterisation of stable cell clones derived from an unusual neuroblastoma stage 4S with MYCN amplificationIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 200ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressivenessIn: Oncogene Jg. 28 (2009) Nr. 19, S. 2015 - 2023ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
LSD 1 is a Potential Therapeutic Target in MedulloblastomaIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 203 - 204ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Lysine-Specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma : Implications for therapyIn: Klinische Pädiatrie / XXII. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung ; Wilsede, Lüneburger Heide, 10.–13. Juni 2009 Jg. 221 (2009) Nr. 3, S. A61ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma : implications for therapyIn: Cancer Research Jg. 69 (2009) Nr. 5, S. 2065 - 2071ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ (Open Access)
-
Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compoundsIn: Clinical Cancer Research Jg. 15 (2009) Nr. 11, S. 3690 - 3696ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
MicroRNAs 221 and 222 in the Pathogenesis of Solid Childhood TumorsIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 210ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
MicroRNAs in the pathogenesis of neuroblastomaIn: Cancer Letters Jg. 274 (2009) Nr. 1, S. 10 - 15ISSN: 0304-3835; 1872-7980Online Volltext: dx.doi.org/
-
N-myc induces transformation of neural crest stem cells in vitro and in vivoIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 195ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Pharmacologic activation of the p53 pathway using Nutlin-3 inhibits medulloblastoma cell proliferation in vitroIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 201ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Prognostic role and functional analyses of miRNA expression in neuroblastomaIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 206ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Proteomics of neuroblastoma master regulatorsIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 209ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome predictionIn: Cancer Letters Jg. 282 (2009) Nr. 1, S. 55 - 62ISSN: 0304-3835; 1872-7980Online Volltext: dx.doi.org/
-
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivoIn: International Journal of Cancer Jg. 124 (2009) Nr. 10, S. 2488 - 2494ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
The miR-17-92 gene cluster is amplified and overexpressed in retinoblastomaIn: Klinische Pädiatrie Jg. 221 (2009) Nr. 3, S. 195ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastomaIn: Molecular Cancer Therapeutics Jg. 8 (2009) Nr. 8, S. 2392 - 2401ISSN: 1535-7163; 1538-8514Online Volltext: dx.doi.org/
-
CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23In: BMC Cancer Jg. 8 (2008) S. 173ISSN: 1471-2407Online Volltext: dx.doi.org/
-
Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cellsIn: DNA Repair Jg. 7 (2008) Nr. 10, S. 1757 - 1764ISSN: 1568-7864; 1568-7856Online Volltext: dx.doi.org/
-
Expression of the p75 neurotrophin receptor reduces tumorigenity of neuroblastoma cells in vivo and in vitroIn: Klinische Pädiatrie Jg. 220 (2008) Nr. 3, S. 206ISSN: 0300-8630; 1439-3824
-
Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomicsIn: International Journal of Cancer Jg. 122 (2008) Nr. 5, S. 1177 - 1182ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Identification of potential new therapeutic and diagnostic targets for neuroblastoma using patient-derived autoantibodiesIn: Klinische Pädiatrie Jg. 220 (2008) Nr. 3, S. 200ISSN: 0300-8630; 1439-3824
-
Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma : a mechanism to inhibit invasionIn: International Journal of Oncology Jg. 32 (2008) Nr. 1, S. 235 - 240ISSN: 1019-6439; 1791-2423Online Volltext: dx.doi.org/ (Open Access)
-
MYCN regulates oncogenic MicroRNAs in neuroblastomaIn: International Journal of Cancer Jg. 122 (2008) Nr. 3, S. 699 - 704ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cellsIn: Clinical Cancer Research Jg. 14 (2008) Nr. 4, S. 1172 - 1181ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
The LSD 1 histone demethylase is highly expressed in poorly differentiated neuroblastoma and is a novel therpeutic targetIn: Klinische Pädiatrie Jg. 220 (2008) Nr. 3, S. 208ISSN: 0300-8630; 1439-3824
-
The role of heat-shock protein 90 in neuroblastoma tumor biologyIn: Klinische Pädiatrie Jg. 220 (2008) Nr. 3, S. 199ISSN: 0300-8630; 1439-3824
-
Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cellsIn: Cancer Letters Jg. 271 (2008) Nr. 1, S. 56 - 63ISSN: 0304-3835; 1872-7980Online Volltext: dx.doi.org/
-
ArrayCGH based classification of neuroblastoma into genomic subgroupsIn: Chromosome research Jg. 15 (2007) Nr. Suppl. 2, S. 82 - 83ISSN: 0967-3849; 1573-6849Online Volltext: dx.doi.org/
-
ArrayCGH-based classification of neuroblastoma into genomic subgroupsIn: Genes, chromosomes & cancer Jg. 46 (2007) Nr. 12, S. 1098 - 1108ISSN: 1045-2257; 1098-2264Online Volltext: dx.doi.org/
-
Correction : Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genesIn: Genome biology Jg. 8 (2007) Nr. 1, S. 401ISSN: 1465-6906; 1465-6914Online Volltext: dx.doi.org/
-
Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cellsIn: Cancer Research Jg. 67 (2007) Nr. 5, S. 2331 - 2338ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumorsIn: International Journal of Cancer Jg. 120 (2007) Nr. 3, S. 533 - 538ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/
-
N-MYC regulates oncogenic micrornas in neuroblastomaIn: Pediatric Blood and Cancer Jg. 49 (2007) Nr. 4, S. 429 - 429ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/
-
N-Myc regulates oncogenic microRNAs in neuroblastomaIn: Klinische Pädiatrie Jg. 219 (2007) Nr. 3, S. 192ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
N-Myc regulates oncogenic micrortnas in neuroblastomaIn: European journal of pediatrics Jg. 166 (2007) Nr. 3, S. 278ISSN: 0340-6199; 1432-1076Online Volltext: dx.doi.org/
-
Neurotrophin receptor status influences the capacity of nonhomologous DNA end joining INSY5Y neuroblastoma cellsIn: Klinische Pädiatrie Jg. 219 (2007) Nr. 3, S. 187 - 187ISSN: 0300-8630; 1439-3824
-
Translating expression profiling into a clinically feasible test to predict neuroblastoma outcomeIn: Clinical Cancer Research Jg. 13 (2007) Nr. 5, S. 1459 - 1465ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Development of a neuroblastoma-specific tissue-microarray as a tool for time- and cost-effective immunohistochemistry analysesIn: Klinische Pädiatrie Jg. 218 (2006) Nr. 3, S. 195ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Expression of TrkA is a potential regulator of immunogenicity in neuroblastoma cellsIn: Klinische Pädiatrie Jg. 218 (2006) Nr. 3, S. 192 - 192ISSN: 0300-8630; 1439-3824
-
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genesIn: Genome biology Jg. 7 (2006) Nr. 9, S. R84ISSN: 1465-6906; 1465-6914; 1474-760XOnline Volltext: dx.doi.org/
-
Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemiaIn: Clinical Cancer Research Jg. 12 (2006) Nr. 8, S. 2434 - 2441ISSN: 1078-0432; 1557-3265Online Volltext: dx.doi.org/
-
Isolation of CD3-/CD56+natural killer cells from whole blood derived buffy coatsIn: Bone Marrow Transplantation Jg. 37 (2006) Nr. Suppl. 1, S. S303ISSN: 1476-5365; 0268-3369Online Volltext: dx.doi.org/
-
Keratoepithelin suppresses the progression of experimental human neuroblastomasIn: Cancer Research Jg. 66 (2006) Nr. 10, S. 5314 - 5321ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
MicroRNA expression analysis in neuroblastoma using pligonuclectide arraysIn: Klinische Pädiatrie Jg. 218 (2006) Nr. 3, S. 194ISSN: 0300-8630; 1439-3824
-
Microarray analysis defines IPL/TSSC3 as a potential target mediating the synergistic effects of combined thermo-chemotherapy in neuroblastoma cellsIn: Klinische Pädiatrie Jg. 218 (2006) Nr. 3, S. 192 - 193ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Application of microarray-based technology to neuroblastomaIn: Cancer letters Jg. 228 (2005) Nr. 1-2, S. 13 - 20ISSN: 0304-3835; 1872-7980Online Volltext: dx.doi.org/
-
Biological effects of TrkA and TrkB receptor signaling in neuroblastomaIn: Cancer letters Jg. 228 (2005) Nr. 1-2, S. 143 - 153ISSN: 0304-3835; 1872-7980Online Volltext: dx.doi.org/
-
Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastomaIn: Oncogene Jg. 24 (2005) Nr. 42, S. 6441 - 6449ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
High activin A-expression in human neuroblastoma : suppression of malignant potential and correlation with favourable clinical outcomeIn: Oncogene Jg. 24 (2005) Nr. 4, S. 680 - 687ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemiaIn: Blood Jg. 106 (2005) Nr. 11, S. 422AISSN: 1528-0020; 0006-4971
-
Identification of dynamic proteome changes upon ligand activation of Trk-receptors using two-dimensional fluorescence difference gel electrophoresis and mass spectrometryIn: Molecular and Cellular Proteomics Jg. 4 (2005) Nr. 3, S. 291 - 299ISSN: 1535-9476; 1535-9484Online Volltext: dx.doi.org/
-
Identification of dynamic proteome changes upon ligand activation of trk-receptors using two-dimensional fluorescence difference gel electrophoresis and mass spectrometryIn: Molecular and Cellular Proteomics Jg. 4 (2005) Nr. 8, S. 1210ISSN: 1535-9476; 1535-9484
-
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomasIn: Oncogene Jg. 24 (2005) Nr. 1, S. 165 - 177ISSN: 0950-9232; 1476-5594
-
Phox2B mutations and the Delta-Notch pathway in neuroblastomaIn: Cancer letters Jg. 228 (2005) Nr. 1-2, S. 59 - 63ISSN: 0304-3835; 1872-7980Online Volltext: dx.doi.org/
-
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingIn: Oncogene Jg. 24 (2005) Nr. 53, S. 7902 - 7912ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
Quantitative phenotyping and discriminant analysis improve scoring classification in late B-lymphoproliferative disordersIn: Blood Jg. 106 (2005) Nr. 11, S. 422AISSN: 1528-0020; 0006-4971
-
Identification of new markers for the detection of minimal residual disease in AML by gene expression profiling and real time PCRIn: Blood Jg. 104 (2004) Nr. 11, S. 554AISSN: 1528-0020; 0006-4971
-
NT-3 mediated signaling pathways in DAOY medulloblastoma cellsIn: Neuro-Oncology Jg. 6 (2004) Nr. 4, S. 409 - 409ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/
-
Structure and function of a regulated archaeal triosephosphate isomerase adapted to high temperatureIn: Journal of Molecular Biology (JMB) Jg. 342 (2004) Nr. 3, S. 861 - 875ISSN: 1089-8638; 0022-2836Online Volltext: dx.doi.org/
-
The Phox2B homeobox gene is mutated in sporadic neuroblastomasIn: Oncogene Jg. 23 (2004) Nr. 57, S. 9280 - 9288ISSN: 0950-9232; 1476-5594Online Volltext: dx.doi.org/
-
Microarray-analysis : a new approach to study the molecular mechanisms of thermo-chemotherapyIn: Klinische Pädiatrie Jg. 215 (2003) Nr. 6, S. 298 - 302ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Proteomics : techniques and applications in cancer researchIn: Klinische Pädiatrie Jg. 215 (2003) Nr. 6, S. 293 - 297ISSN: 0300-8630; 1439-3824Online Volltext: dx.doi.org/
-
Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarraysIn: International journal of oncology Jg. 20 (2002) Nr. 3, S. 441 - 451ISSN: 1019-6439; 1791-2423
-
Pyruvate kinase of the hyperthermophilic crenarchaeote Thermoproteus tenax : Physiological role and phylogenetic aspectsIn: Journal of Bacteriology Jg. 182 (2000) Nr. 7, S. 2001 - 2009ISSN: 0021-9193; 1098-5530Online Volltext: dx.doi.org/ (Open Access)
-
Editorial: MYCN-mediated murine cancer modelsIn: Aging Jg. 9 (2017) Nr. 4, S. 1084 - 1085ISSN: 1945-4589Online Volltext: dx.doi.org/
-
Combining Patient-Derived Xenografts and Barcoding Technology to Evaluate Response to Targeted Therapies in ALK+NSCLCIn: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 611ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/
-
Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C InhibitionIn: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. S586 - S587ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/
-
A Novel Patient Derived Synchronous Cell Pair with Different Mutations in an ALK-Rearranged Lung Adenocarcinoma Underlines Tumor HeterogeneityIn: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S571 - S572ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/ (Open Access)
-
MA17.07 Identification of AHR as a Novel Regulator of Lung Cancer MetastasisIn: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S319ISSN: 1556-1380; 1556-0864Online Volltext: dx.doi.org/ (Open Access)
-
Preclinical investigation of interaction of mistletoe extract (Viscum album L.) with radio- and chemotherapy in pediatric tumor cell lines
7th Mistletoe Symposium: Mistletoe in Tumour Therapy Basic Research and Clinical Practice, 7 - 9 November 2019, Nonnweiler-Otzenhausen, Germany,In: Phytomedicine: International Journal of Phytotherapy and Phytopharmacology Jg. 61 (2019) Nr. Supplement 1, S. 4ISSN: 0944-7113; 1618-095XOnline Volltext: dx.doi.org/ -
Integrated Genomic Analysis Identifies Specific Alterations and Activation of Yap in Relapsed Neuroblastoma
47th Congress of the International Society of Paediatric Oncology (SIOP), October 8–11, 2015, Cape Town, South Africa,In: Pediatric Blood and Cancer Jg. 62 (2015) Nr. S4, S. S145 - S145ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
Soluble NKG2DL are released by Tumor Cell Lines in a Mutually exclusive fashion as free Molecules or via extracellular vesicles
28th EFI European Immunogenetics and Histocompatibility Conference Stockholm, Sweden, June 25th–28th, 2014,In: Tissue Antigens Jg. 84 (2014) Nr. 1, S. 17 - 18ISSN: 0001-2815; 1399-0039Online Volltext: dx.doi.org/ -
ALK F1174L kinase activity as driver of cell proliferation in neuroblastoma cell line models and neuroblastoma tumorsIn: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 1683ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Lysin-Specific Histone Dementhylase 1(LSD1) is a promising new Epigenetic Theapy target Crucially involved in the migration of Medulloblastoma Cells
15th International Symposium on Pediatric Neuro-Oncology, June 24-27 2012 Toronto, Ontario, Canada,In: Neuro-Oncology Jg. 14 (2012) Nr. Suppl. 1, S. i92ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ -
miR-34a is dispensable for normal development but its loss Accelerates medulloblastoma formation
15th International Symposium on Pediatric Neuro-Oncology, June 24-27 2012 Toronto, Ontario, Canada,In: Neuro-Oncology Jg. 14 (2012) Nr. Suppl. 1, S. 89ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ -
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
42nd Congress of the International Society of Pediatric Oncology (SIOP), October 21-24, 2010, Boston, USA,In: Pediatric Blood and Cancer Jg. 55 (2010) Nr. 5, S. 812ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
Deep Sequencing Revals Differential Expression of Micrornas in Favourable Versus Unfavourable Neuroblastoma
42nd Congress of the International Society of Pediatric Oncology (SIOP) in Boston,In: Pediatric Blood and Cancer Jg. 55 (2010) Nr. 5, S. 826 - 827ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
High Expression of the alk Receptor Tyrosine Kinase Precedes Mutation as a Determining Factor of Unfavourable Phenotype in Primary Neuroblastoma
42nd Congress of the International Society of Pediatric Oncology (SIOP), October 21-24, 2010, Boston, USA,In: Pediatric Blood and Cancer Jg. 55 (2010) Nr. 5, S. 827ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
Pharmacologic Activation of the P53 Pathway by Nutlin-3 Inhibits Medulloblastoma Cell Proliferation in Vitro
42nd Congress of the International Society of Pediatric Oncology (SIOP), October 21-24, 2010, Boston, USA,In: Pediatric Blood and Cancer Jg. 55 (2010) Nr. 5, S. 918ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
Exon-Level gene expression analysis of primary neuroblastomas improves risk prediction and identifies jaridic as a novel Therapeutic target
41st Annual conference of International Society of Paediatric Oncology SIOP 2009, Sao Paulo, Brazil, October 5–9, 2009,In: Pediatric Blood and Cancer Jg. 53 (2009) Nr. 5, S. 742 - 743ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
LSD1 is a Potential Therapeutic Target in Medulloblastoma
41st Annual conference of International Society of Paediatric Oncology SIOP 2009, October 5–9, 2009, Sao Paulo, Brazil,In: Pediatric Blood and Cancer Jg. 53 (2009) Nr. 5, S. 826ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
Modeling Neuroblastomagenesis from neural crest Stem Cells in Vitro and in Vivo
41st Annual conference of International Society of Paediatric Oncology SIOP 2009, Sao Paulo, Brazil, October 5–9, 2009,In: Pediatric Blood and Cancer Jg. 53 (2009) Nr. 5, S. 703 - 704ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
The MIR-17-92 Gene Cluster is Amplified an overexpressed in Rettinoblastoma
41st Annual conference of International Society of Paediatric Oncology SIOP 2009, Sao Paulo, Brazil, October 5–9, 2009,In: Pediatric Blood and Cancer Jg. 53 (2009) Nr. 5, S. 735ISSN: 1545-5009; 1545-5017Online Volltext: dx.doi.org/ -
Proteomics and Cancer Risk AssessmentIn: Cancer Risk Evaluation: Methods and Trends / Obe, Günter; Jandrig, Burkhard; Marchant, Gary E.; Schütz, Holger; Wiedermann, Peter M. (Hrsg.) 2011, S. 207 - 217ISBN: 978-3-527-32753-9; 978-3-527-63461-3Online Volltext: dx.doi.org/
-
Identifizierung und Charakterisierung von Kandidatengenen in embryonalen Tumoren durch die Anwendung molekularer HochdurchsatzverfahrenDuisburg, Essen (2008) 1 CD-ROM